Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery

Orthopaedics and Traumatology: Surgery and Research

Volumn 98, Issue 5, 2012, Pages 477-483

  Irisson, E ^a   Hemon Y ^a   Pauly, V ^b   Parratte, S ^b   Argenson, J N ^b   Kerbaul, F ^a,c  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Arthroplasty; Blood transfusion; Cost savings; Tranexamic acid

Indexed keywords

ENOXAPARIN; FONDAPARINUX; IRON; TRANEXAMIC ACID;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG COST; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OSTEOARTHRITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HOSPITAL COSTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84865581993     PISSN: None     EISSN: 18770568     Source Type: Journal    
DOI: 10.1016/j.otsr.2012.05.002     Document Type: Article

References (35)

1. Walker-Bone K., Javaid K., Arden N., Cooper C. Medical magement of osteoarthritis. BMJ 2000, 321:936-940.
2. Samama C.M., Ravaud P., Parent F., Barré J., Merti P., Mismetti P. Epidemiology of venous thromboembolism after lower-limb arthroplasty: the FOTO study. J Thromb Haemost 2007, 5:2360-2367.
3. Rosencher N., Vielpeau C., Emmerich J., Fagnani F., Samama C.M. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost 2005, 3:2006-2014.
4. Scott Beattie W., Karkouti K., Wijeysundera D., Tait G. Risk associated with preoperative anemia in non cardiac surgery. Anesthesiology 2009, 110:574-581.
5. Lienhart A., Auroy Y., Péquignot F., et al. Survey of anesthesia-related mortality in France. Anesthesiology 2006, 105:1087-1097.
6. Zufferey P., Merquiol F., Laporte S., Decousus H., Mismetti P., Auboyer C., et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery. Anesthesiology 2006, 105:1034-1046.
7. Vuillaume C., Fuzier R., Magues J.P., Richez A.S., Bataille B., Bonnevialle P. Blood conservation practices in primary total hip and total knee arthroplasty: a French survey. Rev Chir Orthop 2010, 96:242-247.
8. Kagoma Y.K., Crowther M.A., Douketis J., Bhandari M., Eikelboom J., Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123:687-689.
9. Argenson J.N., Parratte S., Flecher X. Minimally invasive total knee arthroplasty. Rev Chir Orthop 2005, 91:28-30. [In French].
10. Assaps Transfusion de globules rouges homologues: produits, indications, alternatives http://www.afssaps.fr/var/afssaps_site/storage/original/application/67bca30279b4b95b00cf19ae44c3a8ce.pdf.
11. Gilcher R.O., Belcher L. Predeposit programs. Autologous transfusion 1983, 1-10. American Association of Blood Banks, Airlington. 19. G. Sandler, A.J. Silvergleid (Eds.).
12. Hémon Y, Pauly V, Parratte S. Kerbaul F. Stratégie d'épargne transfusionnelle en chirurgie orthopédique réglée à partir d'un algorithme de service. Congrès de la Société française d'anesthésie-réanimation 2008; article R289. http://abstract.mci-group.com/cgi-bin/mc/printabs.pl?APP=SFAR2008-abstract&TEMPLATE=&keyf=0830&showHide=show&client= [In French].
13. Ponchel C., Saby R.C., Gil C., Petrognani R., Carpentier J.P. évaluation du besoin transfusionnel: un moyen d'améliorer la gestion des produits sanguins durant la période périopératoire ?. Med Trop 2005, 65:189-194. [In French].
14. Mercuriali F., Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996, 13:465-478.
15. Shander A., Knight K., Thurer R., Adamson J., Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004, 116(Suppl. 7A):58S-69S.
16. Mantilla C.B., Horlocker T.T., Schroeder D.R., Berry D.J., Brown D.L. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology 2002, 96:1140-1146.
17. Carson J., Terrin M., Noveck H., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011, 365:2453-2462.
18. Nguyen L., Ozier Y. Risques transfusionnels. Reanimation 2008, 17:326-338. [In French].
19. Sukeik M., Alshryda S., Haddad F.S., Mason J.M. Systematic review and meTA-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg (Br) 2011, 93:39-46.
20. Gill J.B., Rosenstein A. The use of antifibrinolytics agents in total hip arthroplasty: a meTA-analysis. J Arthroplasty 2006, 21:869-873.
21. Vastel L., Rosencher N., Siney H., Courpied J.P. Prevention of heterotopic ossifications in hip arthroplasty: effectiveness of selective Cox-2 inhibitors (celecoxib) versus ketoprofen. Rev Chir Orthop 2005, 91:64-69. [In French].
22. Forrest J.B., Camu F., Greer I.A., et al. Ketorolac, diclofenac and ketoprofen are equally safe for pain after major surgery. Br J Anesth 2002, 88:227-233.
23. Garcia-Erce J.A., Cuenca J., Martinez F., Cardona R., Perez-Serrano L., Munoz M. Perioperative intravenous iron preserves iron stores and may hasten the recovery from postoperative anaemia after knee replacement surgery. Transfus Med 2006, 16:335-341.
24. Munoz M., Naveira E., Seara J., Palmer J.H., Cuenca J., Garcia-Erce J.A. Role of parenteral iron in transfusion requirements after total hip replacement: a pilot study. Transfus Med 2006, 16:137-142.
25. Rosencher N., Kerkkamp H., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43:459-469.
26. Faris P.M., Ritter M.A., Abels R.I. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg Am 1996, 78:62-72. The American Erythropoietin Study Group.
27. Horrow J.C., Van Riper D.F., Strong M.D., Grunewald K.E., Parmet J.L. The dose-response relationship of tranexamic acid. Anesthesiology 1995, 82:383-392.
28. Sitbon P. Acide tranexamique en pratique [Mise au point en anesthésie-réanimation, 2009]. http://www.regionmag.com/mapar-protocole-pdf.html [In French].
29. Bellamy L, Rosencher N, Chabbouh T, Arnaout L, Ozier Y. Use of two different regimens of tranexamic acid in major orthopedic surgery. Congrès de l'American Society of Anesthesiologists 2008; article A1151/Congrès de la Société française d'anesthésie-réanimation 2008; article R288. http://abstract.mci-group.com/cgi-bin/mc/printabs.pl?APP=SFAR2008-abstract&TEMPLATE=&keyf=0754&showHide=show&client= [In French].
30. Clavé A., Fazilleau F., Dumser D., Lacroix J. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: a case-control study in 70 patients. Orthop Traumatol Surg Res 2012, doi: 10.116/j.otsr.2011.12.005, [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/22542983.
31. Singh J., Ballal M.S., Mitchell P., Denn P.G. Effects of tranexamic acid on blood loss during total hip arthroplasty. J Orthop Surg (Hong Kong) 2010, 18:282-286.
32. Henry D.A., Carless P.A., Moxey A.J., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007, 4:CD 001886.
33. HAS Récupération de sang périopératoire suivie de son administration par voie intraveineuse 2006, [In French]. http://www.has-sante.fr/portail/jcms/c_432809/recuperation-de-sang-peri-operatoire.
34. Katsumata S., Nagashima M., Kato K., et al. Changes in coagulation-fibrinolysis marker and neutrophil elastase following the use of tourniquet during total knee arthroplasty and the influence of neutrophil elastase on thromboembolism. Acta Anesth Scand 2005, 49:510-516.
35. Weber E.W.G. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalisation. Anesth Analg 2005, 100:1416-1421.